Tortoli Enrico
Regional Reference Center for Mycobacteria, Microbiological and Virological Laboratory, Careggi Hospital, 50134 Florence, Italy.
Clin Microbiol Rev. 2003 Apr;16(2):319-54. doi: 10.1128/CMR.16.2.319-354.2003.
The advancement of genetic techniques has greatly boosted taxonomic studies in recent years. Within the genus Mycobacterium, 42 new species have been detected since 1990, most of which were grown from clinical samples. Along with species for which relatively large numbers of strains have been reported, some of the new species of mycobacteria have been detected rarely or even only once. From the phenotypic point of view, among the new taxa, chromogens exceed nonchromogens while the numbers of slowly and rapidly growing species are equivalent. Whereas conventional identification tests were usually inconclusive, an important role was played by lipid analyses and in particular by high-performance liquid chromatography. Genotypic investigations based on sequencing of 16S rRNA gene have certainly made the most important contribution. The investigation of genetic relatedness led to the redistribution of the species previously included in the classically known categories of slow and rapid growers into new groupings. Within slow growers, the intermediate branch related to Mycobacterium simiae and the cluster of organisms related to Mycobacterium terrae have been differentiated; among rapid growers, the group of thermotolerant mycobacteria has emerged. The majority of species are resistant to isoniazid and, to a lesser extent, to rifampin. Many of the new species of mycobacteria are potentially pathogenic, and there are numerous reports of their involvement in diseases. Apart from disseminated and localized diseases in immunocompromised patients, the most frequent infections in immunocompetent people involve the lungs, skin, and, in children, cervical lymph nodes. The awareness of such new mycobacteria, far from being a merely speculative exercise, is therefore important for clinicians and microbiologists.
近年来,基因技术的进步极大地推动了分类学研究。在分枝杆菌属中,自1990年以来已检测到42个新物种,其中大多数是从临床样本中培养出来的。除了已报道有相对大量菌株的物种外,一些分枝杆菌新物种很少被检测到,甚至仅被检测到一次。从表型角度来看,在新分类群中,产色菌超过非产色菌,而缓慢生长和快速生长物种的数量相当。传统的鉴定试验通常无法得出结论,脂质分析尤其是高效液相色谱发挥了重要作用。基于16S rRNA基因测序的基因型研究无疑做出了最重要的贡献。对遗传相关性的研究导致了先前归入经典的缓慢生长和快速生长类别的物种重新分类到新的分组中。在缓慢生长的物种中,已区分出与猿分枝杆菌相关的中间分支和与地分枝杆菌相关的生物群;在快速生长的物种中,出现了耐热分枝杆菌组。大多数物种对异烟肼耐药,对利福平的耐药程度较低。许多分枝杆菌新物种具有潜在致病性,有大量关于它们引发疾病的报道。除了免疫功能低下患者的播散性和局限性疾病外,免疫功能正常人群中最常见的感染涉及肺部、皮肤,在儿童中还涉及颈部淋巴结。因此,认识到这些新的分枝杆菌,对临床医生和微生物学家来说非常重要,这绝非仅仅是一种推测性的工作。